Wird geladen...
Miliary Tuberculosis in a Crohn's Disease Patient: The Risk beyond the Screening
Tumor necrosis factor alpha (TNFα) antagonist is recognized as an effective treatment to achieve clinical remission and healing mucosal in patients with moderate to severe active Crohn's disease. Considering that it plays a central role in immune-mediated modulation, there are some obvious conc...
Gespeichert in:
| Veröffentlicht in: | GE Port J Gastroenterol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
S. Karger AG
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6341350/ https://ncbi.nlm.nih.gov/pubmed/30675506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487297 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|